ITPC LATCA, based in Guatemala, is one of the few organizations in Central America actively working to reduce the prices of HIV and HCV treatments and improve their affordability. The organization operates in Guatemala, Honduras, and El Salvador while also implementing regional-level initiatives in collaboration with partners in Ecuador, Costa Rica, Paraguay, Bolivia, and the Dominican Republic.
ITPC LATCA has made significant progress in increasing access to essential medicines. The organization has filed patent oppositions on remdesivir and doravirine, contributing to broader efforts to lower drug prices. Leveraging strong relationships with the heads of national HIV programs, LATCA